Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans
Hengameh Shams, Xiaorong Shao, Adam Santaniello, et al.
Brain (2022) Vol. 146, Iss. 2, pp. 645-656
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome
Darin T. Okuda, Orhun H. Kantarci, Christine Lebrun‐Frénay, et al.
Annals of Neurology (2022) Vol. 93, Iss. 3, pp. 604-614
Closed Access | Times Cited: 75
Genetics of multiple sclerosis: lessons from polygenicity
An Goris, Marijne Vandebergh, Jacob L. McCauley, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 9, pp. 830-842
Closed Access | Times Cited: 61
Impact of aging on treatment considerations for multiple sclerosis patients
Gabrielle Macaron, Catherine Larochelle, Nathalie Arbour, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 23
Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions
Alyse de Boer, Aletta M.R. van den Bosch, Nienke Mekkes, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 10
Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic Approaches
Eleni S. Vasileiou, Kathryn C. Fitzgerald
Current Allergy and Asthma Reports (2023) Vol. 23, Iss. 9, pp. 481-496
Closed Access | Times Cited: 19
Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes
Qin Ma, Hengameh Shams, Alessandro Didonna, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 17
Biobanking with genetics shapes precision medicine and global health
C. Scott Gallagher, Geoffrey S. Ginsburg, Anjené Addington
Nature Reviews Genetics (2024)
Closed Access | Times Cited: 5
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications
Geir Bjørklund, David R. Wallace, Tony Hangan, et al.
Autoimmunity Reviews (2025), pp. 103741-103741
Closed Access
Exploring the Pathophysiology, Diagnosis, and Treatment Options of Multiple Sclerosis
Simone Lorenzut, Ilaria Del Negro, Giada Pauletto, et al.
Journal of Integrative Neuroscience (2025) Vol. 24, Iss. 1
Open Access
Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis
Lorena Lorefice, Maristella Pitzalis, Federica Murgia, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 10
Polygenic risk score prediction of multiple sclerosis in individuals of South Asian ancestry
Joshua Robert Breedon, Charles R. Marshall, Gavin Giovannoni, et al.
Brain Communications (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 8
Shifting our attention earlier in the multiple sclerosis disease course
Samantha Epstein, Erin E. Longbrake
Current Opinion in Neurology (2024) Vol. 37, Iss. 3, pp. 212-219
Closed Access | Times Cited: 2
Epigenetic Orchestration of Neurodegenerative Disorders: A Possible Target for Curcumin as a Therapeutic
Shweta Tripathi, Bhawana Bhawana
Neurochemical Research (2024)
Closed Access | Times Cited: 2
Polygenic Risk of Epilepsy and Poststroke Epilepsy
Santiago Clocchiatti‐Tuozzo, Cyprien Rivier, Shubham Misra, et al.
Stroke (2024) Vol. 55, Iss. 12, pp. 2835-2843
Open Access | Times Cited: 2
Polygenicity of Comorbid Depression in Multiple Sclerosis
Kaarina Kowalec, Kathryn C. Fitzgerald, Amber Salter, et al.
Neurology (2023) Vol. 101, Iss. 5
Open Access | Times Cited: 6
Investigating the role of common and rare variants in multiplex multiple sclerosis families reveals an increased burden of common risk variation
Elif Everest, Mohammad Ahangari, Uğur Uygunoğlu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Cellular Therapy in Experimental Autoimmune Encephalomyelitis as an Adjuvant Treatment to Translate for Multiple Sclerosis
Maiara Carolina Perussolo, Bassam Felipe Mogharbel, Cláudia Sayuri Saçaki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6996-6996
Open Access | Times Cited: 1
Novel biomarkers and interferon signature in secondary progressive multiple sclerosis
Avital Fogel, Maya Olcer, Aika Goel, et al.
Journal of Neuroimmunology (2024) Vol. 389, pp. 578328-578328
Closed Access | Times Cited: 1
Consanguineous marriage among familial multiple sclerosis subjects: A national registry-based study
Zahra Salehi, Mohammad Mehdi Naghizadeh, Sajjad Ghane Ezabadi, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32946-e32946
Open Access | Times Cited: 1
Socioeconomic inequalities, genetic susceptibility, and risks of depression and anxiety: A large-observational study
Xin Qi, Yang Jin, Li Liu, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 174-183
Closed Access | Times Cited: 1
Identifying and characterizing disease subpopulations that most benefit from polygenic risk scores
Monica Isgut, Felipe Giuste, Logan Gloster, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Brain lesion characteristics in Chinese multiple sclerosis patients: A 7‐T MRI cohort study
Lei Su, Zhe Zhang, Chenyang Gao, et al.
Annals of Clinical and Translational Neurology (2024)
Open Access | Times Cited: 1
Ensemble machine learning identifies genetic loci associated with future worsening of disability in people with multiple sclerosis
Valery Fuh‐Ngwa, Yuan Zhou, Phillip E. Melton, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
The Ethical, Legal, and Social Implications of Genomics and Disability: Findings from a Scoping Review and Their Human Rights Implications
Maria Vassos, Rhonda Faragher, Karen Nankervis, et al.
Advances in Neurodevelopmental Disorders (2023) Vol. 8, Iss. 1, pp. 151-166
Open Access | Times Cited: 3
Seeking neuroprotection in multiple sclerosis: an ongoing challenge
Jack P. Antel, Timothy E. Kennedy, Tanja Kuhlmann
Journal of Clinical Investigation (2023) Vol. 133, Iss. 7
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top